Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial

STUDY QUESTION: Is oral dydrogesterone 30 mg daily non-inferior to 8% micronized vaginal progesterone (MVP) gel 90 mg daily for luteal phase support in IVF? SUMMARY ANSWER: Oral dydrogesterone demonstrated non-inferiority to MVP gel for the presence of fetal heartbeats at 12 weeks of gestation (non-...

Descripción completa

Detalles Bibliográficos
Autores principales: Griesinger, Georg, Blockeel, Christophe, Sukhikh, Gennady T, Patki, Ameet, Dhorepatil, Bharati, Yang, Dong-Zi, Chen, Zi-Jiang, Kahler, Elke, Pexman-Fieth, Claire, Tournaye, Herman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238366/
https://www.ncbi.nlm.nih.gov/pubmed/30304457
http://dx.doi.org/10.1093/humrep/dey306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238366/
https://www.ncbi.nlm.nih.gov/pubmed/30304457
http://dx.doi.org/10.1093/humrep/dey306

Ejemplares similares